Single-pill HIV treatment to save SA R11bn – health ministry

2017-09-22 22:14
(iStock)

(iStock) (iStock)

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Cape Town - A single-pill HIV treatment is expected to be introduced in 2018 and is projected to save SA about R11bn over the following six years, the health ministry announced on Friday.

In a collaboration with international organisations and agencies, Health Minister Dr Aaron Motsoaledi reached the “breakthrough pricing agreement” which the ministry said would accelerate the availability of the first affordable, generic regimen containing antiretroviral dolutegravir.

“Apart from the financial savings, which will decrease pressure on our national fiscus, its introduction will also have significant benefits for patients,” ministry spokesperson Joe Maila explained in a statement.

“Dolutegravir is a highly effective antiretroviral, which is well tolerated by patients and has fewer side effects. Patients are therefore more likely to be adherent and more likely to be virally suppressed – which means that they are not likely to transmit the virus to others.”

At US$75 per person, per year, the new fixed dose combination will be available to low and middle-income countries at a reduced price, Maila said.

“The large volumes of ARVs purchased by South Africa were used to leverage the decrease in pricing that will benefit all low and middle income countries. The agreement is expected to accelerate treatment rollout as part of global efforts to reach all 36.7 million people living with HIV with high-quality antiretroviral therapy.”

According to the ministry, the HIV programme has grown in the last nine years from 923 000 people to 3.9m at the end of August.

Motsoaledi said the new dolutegravir-based fixed-dose combination will greatly benefit patients due to its “superior therapeutic qualities”.

“The considerable price reductions could yield savings of up to R11.7bn over the next six years for us, which means that we can initiate additional patients on treatment with the same amount of resources. Ramping up treatment with good viral suppression will enable us to reach HIV epidemic control more quickly. We are aiming at launching the new tender in April 2018.”


Read more on:    health  |  hiv & aids

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.
NEXT ON NEWS24X

Inside News24

 
ADVERTORIAL
Competition regulation for a growing and inclusive economy

ADVERTORIAL: The Competition Commission of South Africa is conducting advocacy work in the South African automotive aftermarket industry and has gazetted a Draft Code of Conduct for public comment.

/News
Traffic Alerts
There are new stories on the homepage. Click here to see them.
 
English
Afrikaans
isiZulu

Hello 

Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.


Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Settings

Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.




Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.